This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Convertible Notes: A Form of Early-Stage Financing
Chaplinsky, Susan; Becker, Joseph M.Technical Note DARDEN-F-1925-EFinanceConvertible notes are often used to raise early-stage financing for start-up companies, frequently due to their advantages related to delayed valuation, greater speed, and lower cost of completion compared to venture capital financing. As a result, there has been a large increase in the number of early-stage companies raising capital through convertible notes over the past decade. Investors have made this form of financing more available, believi...Starting at €8.20
-
RadNet, Inc.: Financing an Acquisition
Chaplinsky, Susan; Droznik, AlexCase DARDEN-F-1652-EFinanceThis case examines issues surrounding the choice of financing arrangements for the acquisition of Radiologix in July 2006. The case follows Mark Stolper, the CFO of RadNet, as he considers how to raise the $363 million in funds necessary to finance the acquisition. When completed, the combined firms will be the largest private diagnostic-imaging provider in the United States. When Stolper joined RadNet in 2003, he confronted a company with "too m...Starting at €8.20
-
Investure, LLC: Investing in Alternative Assets
Chaplinsky, SusanCase DARDEN-F-1971-EFinanceIn July 2019, Bruce Miller, CEO of Investure, LLC (Investure), an outsourced chief investment office (OCIO), is preparing a proposal for Franklin and Marshall (F&M), a small liberal arts college located in Lancaster, Pennsylvania, with an endowment of $350 million. F&M recently began a search to find a new endowment manager in hopes of improving its investment returns and access to alternative assets (AA), such as private equity (PE) and hedge fu...Starting at €8.20
-
Novartis: A Transformative Deal
Collis, David J.; Hartman, AshleyCase HBS-717453-EStrategyWhen Joe Jimenez became CEO of Swiss-based Novartis in 2010 replacing longtime CEO Dan Vasella, he assumed control of one of the top pharmaceutical companies in the world. Vasella, an avowed advocate of diversification, had expanded the scope of the company and structured it into sixteen distinct business units ranging from animal health to oncology while "actively fostering competition between those divisions for resources." Shortly after assumi...Starting at €8.20
-
Group Functions at the Maersk Group (Spanish version)
Collis, David J.; Shaffer, MatthewCase HBS-716S21StrategyIn 2014, seven years after he was appointed CEO of the Danish shipping and oil conglomerate A.P. M ller Maersk (the Maersk Group), Nils Andersen was reexamining the size and role of corporate headquarters in the company he had reshaped as a "premium conglomerate." During his tenure, Andersen had divided what had previously been operated as almost a single entity into separate lines of business, each accountable for its own performance and expect...Starting at €8.20
-
Group Functions at the Maersk Group
Collis, David J.; Shaffer, MatthewCase HBS-715432-EStrategyIn 2014, seven years after he was appointed CEO of the Danish shipping and oil conglomerate A.P. M ller Maersk (the Maersk Group), Nils Andersen was reexamining the size and role of corporate headquarters in the company he had reshaped as a "premium conglomerate." During his tenure, Andersen had divided what had previously been operated as almost a single entity into separate lines of business, each accountable for its own performance and expect...Starting at €8.20